FGD5 and lymphoid neoplasm: The expression level of FGD5‐AS1 was significantly different in lymphoid neoplasm diffuse large B‐cell lymphoma (DLBC), GBM, KIRC, LGG, pancreatic adenocarcinoma (PAAD), and THYM (Figure S7A).